The Latest Breaking News from Medicare

Volatility is back in a normal range, and the trend for the main equity indexes remains positive despite specific and general headwinds.

Justice department investigation into health insurance giant reported as company’s CEO says he will retire

UnitedHealth said it was not notified about the “supposed criminal investigation reported.”

Republicans in Congress intend to cut about US$880 billion in federal health care spending.

President Trump recently signed a wide-ranging executive order urging Congress to amend a crucial provision of a Biden-era law governing Medicare drug price negotiations, with the administration’s aim being to lower prices without kneecapping pharmaceutical industry investments in the research and development of innovative new drugs. The executive order marks…

President has directed Robert Kennedy to send price targets to industry, with slimming drugs thought to be included

Elon Musk promised $2 trillion in cuts but delivered only a tiny portion of that total. We asked seven policy experts to explain what he got wrong.

Health policy experts support the ‘most favored nation’ plan but doubt it will withstand likely legal challenges

President Trump's unexpected drug price slash promise rocks global markets.

A House committee releases its plan to reduce the deficit by $880 billion to pay for President Donald Trump’s legislative priorities.

Policy aims to drive drug companies to lower prices domestically while other countries shoulder more of the cost.